NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE19716.30856.5 (+4.54 %)
PREV CLOSE (Rs.) 18859.80
OPEN PRICE (Rs.) 18980.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 896
TODAY'S LOW / HIGH (Rs.)18980.00 19780.30
52 WK LOW / HIGH (Rs.)11500 20072
NSE19697.00826 (+4.38 %)
PREV CLOSE( Rs. ) 18871.00
OPEN PRICE (Rs.) 18960.00
BID PRICE (QTY) 19697.00 (3)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 41310
TODAY'S LOW / HIGH(Rs.) 18882.00 19815.00
52 WK LOW / HIGH (Rs.)11500 20089
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
173.86
Dividend Yield(%)
0.17
TTM EPS (Rs.)
283.01
P/E Ratio
69.67
Book Value (Rs.)
1453.59
Face Value (Rs.)
10
MCap (Rs. in Mn)
252957.94
Price/Earning (TTM)
55.62
Price/Sales (TTM)
12.50
Price/Book (MRQ)
13.56
PAT Margin (%)
17.95
ROCE (%)
27.55
Incorporation Year : 07-01 1984

Management Info :

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone : 040-67611600 / 67611700

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
10Jul Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
16Jun Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
16Jun Neuland Laboratories informs about n
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
QTR Mar 26 ANNUAL 26
Net Profit2125.233631.05
Gross Profit 2870.42 4877.34
Operating Profit 3193.6 6034.09
Net Sales 7762.5 20229.85
Rs. in Millions
Divi's Laboratories (BSE)
 7794.00 (5.03%)
M.Cap (Rs. in Cr)206906.21
Gland Pharma (BSE)
 2544.15 (4.82%)
M.Cap (Rs. in Cr)41968.22
Astrazeneca Pharma (BSE)
 8179.35 (1.36%)
M.Cap (Rs. in Cr)20448.38
Glenmark Pharma. (BSE)
 2261.95 (3.53%)
M.Cap (Rs. in Cr)63832.41
PROMOTERS
32.62%
NON-INSTITUTION
29.79%
MUTUAL FUNDS/UTI
12.66%
FI/BANKS/INSURANCE
1.29%
GOVERNMENT
0%
FII
0%
CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances